
Nephros NEPH
€ 4.28
0.0%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Nephros EV 2011-2025 | NEPH
EV Jährlich Nephros
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.7 M | 9.4 M | 41.3 M | 67.5 M | 75.2 M | 35.5 M | 25.7 M | 25.1 M | 12.2 M | 24.7 M | 9.17 M | 19.8 M | 8.51 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 75.2 M | 8.51 M | 28.9 M |
EV anderer Aktien in der Medizinische Instrumente
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
1.09 B | $ 24.65 | 1.05 % | $ 1.14 B | ||
|
Baxter International
BAX
|
34.3 B | $ 19.49 | 1.72 % | $ 9.94 B | ||
|
Becton, Dickinson and Company
BDX
|
55.5 B | $ 201.36 | 0.2 % | $ 57.9 B | ||
|
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
17.1 M | $ 4.6 | -1.46 % | $ 92.7 M | ||
|
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | ||
|
Harvard Bioscience
HBIO
|
248 M | $ 0.73 | -0.96 % | $ 31 M | ||
|
Alcon
ALC
|
7.12 B | $ 79.68 | 1.1 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
3.34 B | $ 148.09 | -0.23 % | $ 3.61 B | ||
|
AtriCure
ATRC
|
1.93 B | $ 41.89 | -1.17 % | $ 1.97 B | ||
|
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | ||
|
electroCore
ECOR
|
-1.64 M | $ 4.77 | 0.42 % | $ 26.3 K | ||
|
iRhythm Technologies
IRTC
|
3.91 B | $ 169.65 | 0.49 % | $ 5.29 B | ||
|
AngioDynamics
ANGO
|
396 M | $ 13.24 | 0.78 % | $ 541 M | ||
|
The Cooper Companies
COO
|
20.4 B | $ 82.0 | -0.1 % | $ 16.3 B | ||
|
Glaukos Corporation
GKOS
|
4.69 B | $ 110.74 | 1.69 % | $ 5.36 B | ||
|
Repro Med Systems
KRMD
|
93.3 M | $ 5.89 | 1.9 % | $ 269 M | ||
|
Haemonetics Corporation
HAE
|
2.76 B | $ 82.06 | -1.71 % | $ 4.13 B | ||
|
InfuSystem Holdings
INFU
|
197 M | $ 9.24 | - | $ 191 M | ||
|
Isoray
ISR
|
13.3 M | - | 0.03 % | $ 108 M | ||
|
LeMaitre Vascular
LMAT
|
2.26 B | $ 83.88 | -0.14 % | $ 1.88 B | ||
|
Masimo Corporation
MASI
|
10.4 B | $ 137.07 | -0.92 % | $ 7.31 B | ||
|
Merit Medical Systems
MMSI
|
6.6 B | $ 86.34 | -0.42 % | $ 5.03 B | ||
|
Intuitive Surgical
ISRG
|
203 B | $ 557.84 | 2.86 % | $ 198 B | ||
|
Microbot Medical
MBOT
|
13.1 M | $ 2.33 | -3.5 % | $ 23.8 M | ||
|
OraSure Technologies
OSUR
|
60.6 M | $ 2.51 | 0.81 % | $ 187 M | ||
|
Milestone Scientific
MLSS
|
70.1 M | $ 0.35 | -9.85 % | $ 27.9 M | ||
|
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
2.61 B | $ 22.15 | 0.82 % | $ 3.81 B | ||
|
ResMed
RMD
|
36.5 B | $ 254.83 | 0.98 % | $ 37.2 B | ||
|
Pro-Dex
PDEX
|
175 M | $ 43.88 | 1.15 % | $ 144 M | ||
|
Pulse Biosciences
PLSE
|
389 M | $ 14.44 | 1.39 % | $ 694 M | ||
|
STAAR Surgical Company
STAA
|
800 M | $ 23.95 | -0.75 % | $ 1.18 B | ||
|
STERIS plc
STE
|
27.5 B | $ 253.14 | 0.49 % | $ 25 B | ||
|
Stereotaxis
STXS
|
216 M | $ 2.37 | - | $ 191 M | ||
|
Predictive Oncology
POAI
|
12.7 M | - | - | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
126 M | $ 160.0 | 1.66 % | $ 8.92 M | ||
|
Utah Medical Products
UTMD
|
162 M | $ 58.1 | - | $ 211 M | ||
|
DENTSPLY SIRONA
XRAY
|
7.04 B | $ 11.6 | 0.22 % | $ 2.36 B | ||
|
Retractable Technologies
RVP
|
90.3 M | $ 0.82 | -0.66 % | $ 24.5 M | ||
|
Teleflex Incorporated
TFX
|
8.74 B | $ 128.08 | 1.11 % | $ 6 B | ||
|
West Pharmaceutical Services
WST
|
15.9 B | $ 268.47 | 0.34 % | $ 19.6 B |